Table V.7

Table V.7: The Number of States Reporting Each Level of Satisfaction with FDA Communication Regarding Drug Compounding
Number of states^a
Very satisfied	Somewhat satisfied	Neither satisfied nor dissatisfied	Somewhat dissatisfied	Very dissatisfied	No response
17	7	5	7	2	2

^{Source: GAO survey of state pharmacy regulatory bodies, survey question 36. | GAO-17-363SP}

Notes: GAO surveyed the state pharmacy regulatory bodies in the 50 states, the District of Columbia, Guam, Puerto Rico, and the U.S. Virgin Islands, and all but 4 completed the survey.

^aForty states that reported having had communication or interactions with the Food and Drug Administration (FDA) related to drug compounding issues were asked about their overall satisfaction with that communication or interaction.